Many claim that engineering simulation in healthcare will be critical. The only way to get a clear and complete answer would be to ask the question “Is simulation essential for healthcare?” to the people using computer modeling and simulation (CM&S) routinely for medical device design, biotech or pharmaceutical process modeling during the ANSYS Healthcare Innovation Conference in Cambridge, MA on May 10th. Continue reading
Because of the growing emphasis on the Internet of Things (IoT), a large number of analysts see the healthcare market as one of the biggest opportunities for high-tech. As a specialist in the healthcare business, I certainly agree that the next major step for healthcare requires treating pathologies in the very early stages, what IoT technology will enable. Early treatments are usually easier, cheaper and maximize the chance for a complete cure. This is called P4 medicine — preventive, participatory, predictive, personalized. But this requires continuously measuring many parameters within our bodies. If we don’t want to live with our physician, we need to wear the necessary measurement equipment and this is where the new high-tech industry plays a role. Continue reading
“Innovation in healthcare is not just a question of business; often it is a matter of life and death. Medical and pharmaceutical companies must turn a profit, but they also have an ethical duty to improve lives — addressing common chronic illnesses and providing effective treatments for rare conditions — no matter the lack of profitability. Healthcare companies, therefore, face the dilemma of how to minimize cost and maximize efficiency.” Continue reading
The world of multiphysics simulation is growing ever more ambitious each year. That is obvious from this year’s ANSYS Hall of Fame Competition, for which the company recently selected five top entries that typify the best of the best.
From a company developing new spinal instruments to reduce the risks of scoliotic surgery, to a university’s examination of how a leatherback turtle would weather climate change, this year’s top five represented contributions from multiple industries and amazing applications. Continue reading
A few weeks ago, I participated to the biomedical track of the ANSYS CADFEM Users Meeting (ACUM) in Nuremberg, Germany — an amazing meeting where many medical device companies, academic leaders, clinicians and surgeons shared their experiences and stressed the need to accelerate the adoption of engineering simulation for medical and clinical applications. Continue reading
There are many fascinating medical evolutions that designers and engineers will discuss next week at the Pacific Design & Manufacturing Show in Anaheim, CA. Let me share one example, among many, for which engineering simulation plays a key role.
Advances in Implantable Medical Devices
With the world’s population aging, we can enjoy interacting with our parents and grandparents much longer than previous generations did. What is really even better is that their quality of life is improving. Today we can continuously monitor conditions that typically affect the elderly, such as heart malfunction, fluctuating blood glucose levels and hearing troubles. In fact, some implantable devices — like the implantable cardioverter-defibrillator (ICD) that corrects heart arrhythmia — connect to the web so they can immediately and transparently call for medical assistance if there is a sudden change in the patient’s health statistics. Continue reading